1950 Shades of Pinks and Greys: Was L. Ron Hubbard Drugged Out When He Developed OT III?

Former Scientology archivist and ex-Scientologist Gerald “Gerry” Armstrong asserts that founder L. Ron Hubbard drank and used drugs in 1967 at Las Palmas when he researched OT III (Operating Thetan Level 3), per a purported letter admitting such to his wife Mary Sue Hubbard. Armstrong never introduc...

Full description

Saved in:  
Bibliographic Details
Main Author: Camacho, Ian C. (Author)
Format: Electronic Article
Language:English
Check availability: HBZ Gateway
Journals Online & Print:
Drawer...
Fernleihe:Fernleihe für die Fachinformationsdienste
Published: [2021]
In: The journal of CESNUR
Year: 2021, Volume: 5, Issue: 4, Pages: 3-57
Further subjects:B OT III
B Captain Bill Robertson
B L. Ron Hubbard
B Scientology
B Mary Sue Hubbard
B Scientology and Fake News
B Gerry Armstrong
B Janis Gillham-Grady
B Virginia Downsborough
B Pinks and Greys
Online Access: Volltext (lizenzpflichtig)
Description
Summary:Former Scientology archivist and ex-Scientologist Gerald “Gerry” Armstrong asserts that founder L. Ron Hubbard drank and used drugs in 1967 at Las Palmas when he researched OT III (Operating Thetan Level 3), per a purported letter admitting such to his wife Mary Sue Hubbard. Armstrong never introduced the letter into court as evidence, nor did it appear in any court transcript, which Armstrong freely admits. All of Hubbard’s letters to Mary Sue in the evidence log either lack descriptions or dates. Notably, Armstrong made this claim after the trial, and others soon echoed him. These claims do not hold up well under scrutiny, however, as many self-contradict or contradict each other. Furthermore, publicly available articles and earlier testimonies give an opposite narrative. While Hubbard’s whereabouts and activities in 1967 remain unclear, the burden of proof rests on the accusers, given that the currently available evidence suggests otherwise.
ISSN:2532-2990
Contains:Enthalten in: The journal of CESNUR
Persistent identifiers:DOI: 10.26338/tjoc.2021.5.4.1